CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
RAMPART aims to enhance cancer treatment by identifying biomarkers of tumor resistance in Head and Neck Squamous Cell Carcinoma. Using advanced imaging techniques, it seeks to provide rapid insights into tumor responses to therapies, facilitating personalized treatment strategies.
RAMPART aims to address the significant clinical challenge of tumor resistance to anticancer therapies, a key factor contributing totreatment failure and decreased patient survival, particularly in Head and Neck Squamous Cell Carcinoma (HNSCC).
The project’sprimary objective is to develop a label-free, nondestructive and rapid methodology using Raman and multimodal imaging to identifybiomarkers of tumor resistance, by monitoring the biochemical responses of ex vivo patient-derived tumor slices t…
POLITECNICO DI MILANO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Jena
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United States, Baltimore
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
